Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-2.08	192.36	196.44
Graham Fair Price	< 0.005	1.14	1.14
PEG	inf	0.00	0.04
Price/Book	-6.51	0.15	0.16
Price/Cash Flow	-6.51	4.79	5.13
Prices/Earnings	6.51	-5.89	-6.30
Price/Sales	-6.51	0.12	0.12
Price/FCF	-6.51	4.79	5.13
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.04	0.04
Operating Margin	0.00	< 0.005	< 0.005
ROA	0.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	< 0.005
ROIC	< 0.005	< 0.005	0.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.05	-90.85
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-1.10	0.00	inf
EPS QOQ	-1.66	0.00	inf
FCF QOQ	6.22	0.00	inf
Revenue QOQ	< 0.005	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1.10	1.10	0.00
Days Sales Outstanding (DSO)	233.03	233.03	0.00
Inventory Turnover	82.14	82.14	0.00
Debt/Capitalization	0.29	0.29	0.34
Quick Ratio	1.14	1.12	-1.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3.02	3.02	< 0.005
Cash	0.72	0.51	-28.98
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.09	0.09	0.00
Revenue	3.89	3.89	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.25	1.25	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	119.23	120.17	0.79
Naive Interpretation	Member

06 - Financial Health · Weak

Rating